Home
BenaGene Introduction
How It Works
Anti-Aging Life Extension
Glucose Management
Weight Management
Genomic Changes
Contact Us
benaGene News
Online Distributors

 

 

 

 

 Natural Glucose Control 

Ingredients in benaGene have been the subject of several clinical trials to reduce glucose.  The patients at highest risk (diabetics) showed an average fasting glucose reduction of 23.7 +/- 3.4%.  Not just for diabetics, however, glucose reduction was also seen in non-diabetics and animals during the trials.  The ages tested ranged from 17 years old to 95 years old showing no side effects in the 30 to 45 day study.  The results of these clinical trials can be seen in the following tables.

 

Maximal

Fasting Glucose

 

 

 

Age

Dose (mg)

Before

After

% Reduction

Side Effects

90

600

200

120

40.0%

None

17

600

287

230

19.9%

None

57

600

157

113

28.0%

None

45

600

226

201

11.1%

None

50

300

180

116

35.6%

None

15

300

245

104

57.6%

None

92

300

84

78

7.1%

None

23

200

200

180

10.0%

None

52

300

190

167

12.1%

None

70

200

183

167

8.7%

None

48

300

175

151

13.7%

None

45

900

294

215

26.9%

None

33

200

195

181

7.2%

None

48

400

195

162

16.9%

None

49

1,000

149

100

32.9%

None

32

300

224

198

11.6%

None

53

1,000

115

104

9.6%

None

95

300

180

116

35.6%

None

54

300

190

114

40.0%

None

50

600

230

106

53.9%

None

90

100

134

109

18.7%

None

 

 

 

 

 

Average 23.7%

Change in Glucose Uptake in blood serum for diabetic and normal patients are shown below.  The increase in glucose uptake indicates a decrease in insulin resistance, and also leads to less glucose in the blood stream.  Having less glucose available leads to lower rates of protein glycation.  In diabetic patients, the increase in glucose uptake averaged 299%.  In normal patients, the increase averaged 180%.

Diabetic
Patient Before After % Increase
1 1.59 6.4 303%
2 1.46 6.09 317%
3 2.13 9.29 336%
4 0.62 9.29 1398%
5 5.43 8.47 56%
6 3.07 4.57 49%
7 1.79 4.83 170%
8 5.4 6.21 15%
9 0.88 3.72 323%
10 3.67 4.58 25%
Average 299%
Non-Diabetic
Patient Before After % Increase
1 11.72 11.42 -3%
2 12.39 11.57 -7%
3 4.18 8.51 104%
4 5.22 7.38 41%
5 5.5 8.45 54%
6 8.99 10.55 17%
7 5.9 8.54 45%
8 5.24 9.25 77%
9 2.64 5.93 125%
10 2.41 7.18 198%
11 3.09 3.89 26%
12 3.25 8.9 174%
13 3.26 4.4 35%
14 1.42 0.67 -53%
15 0.27 5.32 1870%
Average 180%

Site Mailing List 
These statements have not been evaluated by the FDA. The product is not intended to diagnose, treat, cure, or prevent any disease.

@2009 all information
Terra Biological LLC

Site Powered By
    WebBizBuilder Site Manager
    Online web site design